A9537 HCPCS code: Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries
A9537 is the HCPCS Level II code for technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries. In 2024 Medicare paid an average of $34.40 per service for A9537 across 5,876 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 1 per day on outpatient hospital claims. Medicare volume fell 10% from 2022 to 2024 (6,538 to 5,876 services). In 2024, about 1,071 clinicians billed Medicare for A9537 for 5,849 beneficiaries; Florida, Texas, California accounted for 38% of services.
Code details
| Field | Value |
|---|---|
| Section | A codes — Transportation, medical/surgical supplies and miscellaneous |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 57 |
| BETOS category | I1E |
| Added | 2006-01-01 |
| Last action effective | 2006-01-01 |
Who bills A9537 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,071 |
| Medicare beneficiaries | 5,849 |
| States with claims | 40 |
| Share of services in top 3 states (Florida, Texas, California) | 38% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for A9537, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 6,538 | 6,513 | $43.07 | $34.06 |
| 2023 | 6,002 | 5,974 | $43.35 | $34.35 |
| 2024 | 5,876 | 5,849 | $43.43 | $34.40 |
States with the most A9537 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 1,335 | $7.39 |
| Texas | 485 | $36.11 |
| California | 437 | $47.17 |
| New York | 365 | $41.14 |
| Maryland | 359 | $46.96 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 1 | Code Descriptor / CPT Instruction |
| practitioner claims | 1 | Code Descriptor / CPT Instruction |
What changed for A9537
- 2006-01-01: A9537 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code A9537?
A9537 is the HCPCS Level II code for technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries. Short descriptor: "Tc99m mebrofenin".
How much does Medicare pay for A9537?
In 2024, the average Medicare payment was $34.40 per service (average allowed $43.43).
Does Medicare cover A9537?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of A9537 can be billed per day?
1 on outpatient hospital claims; 1 on practitioner claims (NCCI medically unlikely edits).
Related A95 codes
- A9500 — Technetium tc-99m sestamibi, diagnostic, per study dose
- A9501 — Technetium tc-99m teboroxime, diagnostic, per study dose
- A9502 — Technetium tc-99m tetrofosmin, diagnostic, per study dose
- A9503 — Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries
- A9504 — Technetium tc-99m apcitide, diagnostic, per study dose, up to 20 millicuries
- A9505 — Thallium tl-201 thallous chloride, diagnostic, per millicurie
- A9506 — Graphite crucible for preparation of technetium tc 99m-labeled carbon aerosol, one crucible
- A9507 — Indium in-111 capromab pendetide, diagnostic, per study dose, up to 10 millicuries
- A9508 — Iodine i-131 iobenguane sulfate, diagnostic, per 0.5 millicurie
- A9509 — Iodine i-123 sodium iodide, diagnostic, per millicurie
- A9510 — Technetium tc-99m disofenin, diagnostic, per study dose, up to 15 millicuries
- A9512 — Technetium tc-99m pertechnetate, diagnostic, per millicurie
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under A9537
- Watch A9537 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for A9537
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.